05:03 PM EDT, 06/20/2024 (MT Newswires) -- Hans van Houte, Chief Financial Officer, on June 20, 2024, sold 20,000 shares in Nurix Therapeutics ( NRIX ) for $400,216. Following the Form 4 filing with the SEC, Van Houte has control over a total of 48,333 shares of the company, with 48,333 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1549595/000154959524000088/xslF345X03/wk-form4_1718917093.xml
Price: 20.30, Change: -0.67, Percent Change: -3.20